Participants will be randomized at a 2: 1 ratio to receive new pharmaceutical form Minoxidil 5% and placebo, respectively. Through this method, it is possible to obtain more information about the effectiveness of investigational product.~The primary objective of the study is to evaluate efficacy by assessing nonvellus target area hair count after using a new topical formulation of Minoxidil 5% compared to placebo applied topically for 24 weeks.~Among the secondary objectives, other aspects of effectiveness and safety will be evaluated, such as quality of life, vital signs, and other parameters.~⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).
A prospective, randomized, double-blind, single-center, placebo-Controlled, parallel-group study to evaluate the efficacy and safety of a new pharmaceutical form Minoxidil 5% in men after 24 weeks of treatment.~⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).